Referenser Hidradenit

1. Zouboulis CC et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015; 29:619-44.
2. Johnston L, Alhusayen R, Bourcier M et al. Practical Guidelines for managing patients with hidradenitis suppurativa: an update. J Cutan Med Surg 2022;26:25-245
3. Riis PT et al. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series. J Am Acad Dermatol. 2016; 75:1151-5.
4. Thrasyvoulos T, Zouboulis C. Which hidradenitis suppurativa comorbidities should I take into account? Exp Dermatol 2022;31:29-32.
5. Zouboulis C, Bechara F, Dickinson-Blok J, Gulliver W, Horváth B et al. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol 2019;33:19-31.
6. Goldburg S, Strober B, Payette M. Hidradenitis suppurativa. Current and emerging treatments. J Am Acad Dermatol 2020;82:1061-82.
7. Regionala riktlinjer 2020-12-31, https://vardgivare.skane.se/vardriktlinjer/hud-och-kon/ako/hidradenitis-suppurativa/
8. Orenstein L, Nguyen T, Damiani G, Sayed C, Jemec G, Hamzavi I. Medical and Surgical Management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice. Dermatology 2020;236:393-412
9. Straalen K, Prens E, Gudjonsson J. Insights into hidradenitis suppurativa. J Allergy Clin Immunol 2022;149:1150-1161.
10. Hasan S, Harris C, Collier F Hidradenitis suppurativa BMJ: 2022 ;379:e068383
11. Killasli H, Sartorius K, Emtestam L, Svensson Å. Hidradenitis suppurativa in Sweden: A registry-based cross-sectional study of 13538 patients. Dermatology 2020,236:281-288.
12. Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jernec G. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol 2021;35:50-61.
13. Vinding G, Miller I, Zarchi K et al. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 2014; 170:884-889.
14. Chernyshov P, Zouboulis C, Tomas-Aragones L, Jemec G, Svensson A et al. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on quality of life and patient-oriented outcomes and acne, rosacea and hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2019;33:1633-1643.